Lauren Shapiro

823 total citations
14 papers, 87 citations indexed

About

Lauren Shapiro is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Lauren Shapiro has authored 14 papers receiving a total of 87 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Lauren Shapiro's work include Acute Myeloid Leukemia Research (5 papers), COVID-19 and healthcare impacts (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Lauren Shapiro is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), COVID-19 and healthcare impacts (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Lauren Shapiro collaborates with scholars based in United States, Netherlands and Israel. Lauren Shapiro's co-authors include Aditi Shastri, Sofía de Oliveira, Amit Verma, Kelsie Cowman, Priya Nori, Mendel Goldfinger, Bonnie LaFleur, Jeremy Tey, Ohad Benjamini and Noah Kornblum and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Lauren Shapiro

11 papers receiving 85 citations

Peers

Lauren Shapiro
Salman Otoukesh United States
Olga Skibina Australia
Irogue Igbinosa United States
Maxi Wass Germany
Divya Koura United States
Colleen Timlin United States
Salman Otoukesh United States
Lauren Shapiro
Citations per year, relative to Lauren Shapiro Lauren Shapiro (= 1×) peers Salman Otoukesh

Countries citing papers authored by Lauren Shapiro

Since Specialization
Citations

This map shows the geographic impact of Lauren Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren Shapiro more than expected).

Fields of papers citing papers by Lauren Shapiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren Shapiro. The network helps show where Lauren Shapiro may publish in the future.

Co-authorship network of co-authors of Lauren Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren Shapiro. A scholar is included among the top collaborators of Lauren Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren Shapiro. Lauren Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Pradhan, Kith, Liam Townsend, Mendel Goldfinger, et al.. (2025). Efficacy and manageable toxicity of mogamulizumab in a real-world North American cohort of adult T-cell leukemia/lymphoma (ATLL).. Journal of Clinical Oncology. 43(16_suppl).
2.
Hammami, M Bakri, Mendel Goldfinger, Nishi Shah, et al.. (2024). Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort. Transplantation and Cellular Therapy. 30(5). 544.e1–544.e8. 3 indexed citations
3.
Levitz, David, Yogen Saunthararajah, Lauren Shapiro, et al.. (2023). A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML. Clinical Cancer Research. 29(15). 2774–2780. 10 indexed citations
4.
Davis, Timothy M. E., Lauren Shapiro, Aditi Shastri, et al.. (2023). High Dose Cyclophosphamide for the Treatment of Severe Immune Checkpoint Inhibitor Related Adverse Events. PubMed. 8(4).
5.
Lee, Ainsley Ryan Yan Bin, Lauren Shapiro, Astha Thakkar, et al.. (2022). Booster doses of COVID-19 vaccines for patients with haematological and solid cancer: a systematic review and individual patient data meta-analysis. European Journal of Cancer. 172. 65–75. 26 indexed citations
6.
Shapiro, Lauren, Ioannis Mantzaris, Aditi Shastri, et al.. (2022). Low-dose weekly decitabine and venetoclax in TP53-mutated myeloid malignancies.. Journal of Clinical Oncology. 40(16_suppl). e19005–e19005. 1 indexed citations
7.
Levitz, David, Kith Pradhan, Lauren Shapiro, et al.. (2022). A Non-Cytotoxic Regimen Using a Weekly Low Dose Decitabine and Venetoclax for MDS and AML in a Real World Cohort. Blood. 140(Supplement 1). 6218–6219. 3 indexed citations
8.
Shapiro, Lauren, et al.. (2021). Therapeutic targeting of the inflammasome in myeloid malignancies. Blood Cancer Journal. 11(9). 152–152. 22 indexed citations
9.
Gordon, Shanisha, Srinivas Aluri, Yang Shi, et al.. (2021). A Transgenic Murine Model Expressing Hyperactive STAT3 Recapitulates the Features of MDS/AML. Blood. 138(Supplement 1). 3308–3308.
10.
Shapiro, Lauren, Ioannis Mantzaris, Aditi Shastri, et al.. (2021). Low-Dose Weekly Decitabine and Venetoclax in TP53-Mutated Myeloid Malignancies. Blood. 138(Supplement 1). 4428–4428. 1 indexed citations
11.
Hoffman, Emily, Kelsie Cowman, Lauren Shapiro, & Priya Nori. (2021). Respiratory Illness Presenteeism in Academic Medicine: A Conceivable COVID‐19 Culture Change for the Better. Journal of Hospital Medicine. 16(5). 308–310. 2 indexed citations
13.
Merkin, Ross D., et al.. (2020). Internal Medicine Resident Work Absence During the COVID-19 Pandemic at a Large Academic Medical Center in New York City. Journal of Graduate Medical Education. 12(6). 682–685. 7 indexed citations
14.
Cowman, Kelsie, et al.. (2019). Understanding drivers of influenza-like illness presenteeism within training programs: A survey of trainees and their program directors. American Journal of Infection Control. 47(8). 895–901. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026